检索范围:
排序: 展示方式:
Telomeric impact of conventional chemotherapy
null
《医学前沿(英文)》 2013年 第7卷 第4期 页码 411-417 doi: 10.1007/s11684-013-0293-z
The increased level of chromosome instability in cancer cells, leading to aneuploidy and gross chromosomal rearrangements, is not only a driving force for oncogenesis but also can be the Achille’s heel of the disease since many chemotherapies (CT) kill cells by inducing a non-tolerable rate of DNA damage. A wealth of published evidence showed that telomere stability can be more affected than the bulk of the genome by several conventional antineoplasic drugs. These results raise the interesting possibility that CT with genotoxic drugs preferentially target telomeres. In agreement with this view, accelerated shortening of telomere length has been described in blood lineage cells following high-dose CT (stem cell transplantation) or non-myeloablative CT. However, almost nothing is known on the consequences of this shortening in terms of telomere stability, senescence and on the development of second cancers or post-treatment aging-like syndromes in cancer survivors (cognitive defect, fertility impairment, etc.). In this article, we propose: (1) telomeres of cancer cells are preferential genomic targets of chemotherapies altering chromosome maintenance; (2) telomere functional parameters can be a surrogate marker of chemotherapy sensitivity and toxicity; (3) the use of anti-telomere molecule could greatly enhance the sensitivity to standards chemotherapies.
关键词: telomere antineoplasic drugs conventional chemotherapies
Repurposing clinical drugs is a promising strategy to discover drugs against Zika virus infection
Weibao Song, Hongjuan Zhang, Yu Zhang, Rui Li, Yanxing Han, Yuan Lin, Jiandong Jiang
《医学前沿(英文)》 2021年 第15卷 第3期 页码 404-415 doi: 10.1007/s11684-021-0834-9
关键词: Zika virus clinical drugs ZIKV inhibitors antivirals repurposing
Small-molecule anti-COVID-19 drugs and a focus on China’s homegrown mindeudesivir (VV116)
《医学前沿(英文)》 doi: 10.1007/s11684-023-1037-3
Peng Hu, Changsheng Guo, Yan Zhang, Jiapei Lv, Yuan Zhang, Jian Xu
《环境科学与工程前沿(英文)》 2019年 第13卷 第4期 doi: 10.1007/s11783-019-1140-5
We developed a method for determining 11 abused drugs in water and sediment. METH and EPH were the dominant drugs in water and sediment in Beiyunhe River. Abuse drugs in Beiyunhe River were mainly from hospitals and sewage effluents. Abused drugs in the water would not impair the aquatic ecosystem biologically.
关键词: Drugs of abuse Occurrence Distribution Urban river Environmental risk
Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)
《医学前沿(英文)》 2022年 第16卷 第5期 页码 815-826 doi: 10.1007/s11684-021-0891-0
关键词: B-cell lymphoma oral drug targeted therapy immunotherapy COVID-19 pandemic
Vaibhav Mundra, Ram I. Mahato
《化学科学与工程前沿(英文)》 2014年 第8卷 第4期 页码 387-404 doi: 10.1007/s11705-014-1457-3
关键词: nanocarrier cellular uptake endosomal release nucleic acid drug
《环境科学与工程前沿(英文)》 2022年 第16卷 第7期 doi: 10.1007/s11783-021-1501-8
• Oxidation of methotrexate by high-valent metal-oxo species was first explored.
关键词: Anticancer drugs High-valent metal-oxo species Oxidation kinetics Reaction mechanisms Multi-endpoint toxicity
null
《医学前沿(英文)》 2012年 第6卷 第1期 页码 22-34 doi: 10.1007/s11684-012-0178-6
Stroke is a personal, familial, and social disaster. It is the third cause of death worldwide, the first cause of acquired disability, the second cause of dementia, and its cost is astronomic. The burden of stroke is likely to increase given the aging of the population and the growing incidence of many vascular risk factors. Prevention of stroke includes—as for all other diseases—a “mass approach” aiming at decreasing the risk at the society level and an individual approach, aiming at reducing the risk in a given subject. The mass approach is primarily based on the identification and treatment of vascular risk factors and, if possible, in the implementation of protective factors. These measures are the basis of primary prevention but most of them have now been shown to be also effective in secondary prevention. The individual approach combines a vascular risk factor modification and various treatments addressing the specific subtypes of stroke, such as antiplatelet drugs for the prevention of cerebral infarction in large and small artery diseases of the brain, carotid endarterectomy or stenting for tight carotid artery stenosis, and oral anticoagulants for the prevention of cardiac emboli. There is a growing awareness of the huge evidence-to-practice gap that exists in stroke prevention largely due to socio-economic factors. Recent approaches include low cost intervention packages to reduce blood pressure and cheap “polypills” combining in a single tablet aspirin and several drugs to lower blood pressure and cholesterol. Polypill intake should however not lead to abandon the healthy life-style measures which remain the mainstay of stroke prevention.
关键词: stroke prevention vascular risk factors cerebral infarction cerebral hemorrhage anti-thrombotic drugs carotid endarterectomy
Factors related to compliance with oral analgesic treatment of inpatients with chronic pain
null
《医学前沿(英文)》 2015年 第9卷 第3期 页码 374-379 doi: 10.1007/s11684-015-0411-1
This study aimed to determine the relationship between the different factors of analgesic therapy and the compliance of chronic pain inpatients. We prospectively investigated 100 consecutive inpatients with non-cancer chronic pain who were hospitalized to receive oral analgesic treatment in the Pain Department of West China Hospital from May 2013 to October 2013. Patients who completed the treatment plan were recorded as good compliance, whereas patients who partly completed or even refused the treatment were recorded as moderate or non-compliance, respectively. A total of 73 (73.7%), 17 (17.1%), and 9 (9.2%) patients showed good, moderate, and non-compliance, respectively. Univariate analyses showed significantly better compliance among farmers, patients educated in college or above, with family income of<3000 CNY, and with severe or moderate pain than those employed and unemployed (P=0.02), patients educated below college (P=0.013), with family income of≥3000 CNY (P=0.025), and with mild pain (P<0.001), respectively. Logistic regression analysis showed that the family income of≥3000 CNY (OR: 2.50, 95%CI: 1.65–4.51, P=0.021) and mild pain (OR: 1.27, 95%CI: 1.03–3.31, P=0.016) were associated with moderate or non-compliance with oral analgesic treatment. In conclusion, the low compliance with oral treatment of analgesics was found in Chinese inpatients with chronic pain and compliance was negatively associated with family income and degree of pain of patients.
《化学科学与工程前沿(英文)》 2023年 第17卷 第10期 页码 1503-1515 doi: 10.1007/s11705-022-2294-4
关键词: insoluble drugs polymer inhibition crystallization crystal growth kinetics DFT calculations
张勇,赵一秀,杨宝峰
《中国工程科学》 2021年 第23卷 第1期 页码 185-192 doi: 10.15302/J-SSCAE-2021.01.022
整合药学是以现代药学为基础、随着人类对复杂性疾病认识的日益深刻而提出来的,涉及新药研发、传统医药创新、 临床药学实践、药学学科建设及人才培养等诸多领域。为推进我国整合药学实践的发展,本文运用文献研究、学术交流、专 家咨询等方法,阐明了整合药学理念及内涵,提出了整合药学的未来发展战略。研究指出,要促进现代药学与传统药学的整 合,应建立健全整合用药临床实践指南、鼓励基于整合思维的创新中药研究、规范整合中西药临床应用;推进基于整合药学 的新药研发,应创新整合药物设计思路、开发适应整合药学的药物评价体系、加快建设整合药物的新药研发体系;推进整合 药学的临床实践,应进一步完善以患者为中心的临床用药指导、实现个体化治疗、丰富整合药学临床实践内容、加强整合药 物合理应用;推进整合药学学科建设,应丰富基于整合药学的药学本科理论和实践课程、加强教育培训及专业间协作。整合 药学是现代药学理论和实践的变革与发展,融合药学各相关学科的理论与实践,是构建促进人类健康、完善医疗体系的新型 药学理论和实践体系。
于德泉
《中国工程科学》 1999年 第1卷 第2期 页码 87-90
文章展望了从天然产物中创制新药的发展趋势。单味中草药有效成分的研究重点将转向瞄准质控的中药复方化学成分研究。进入21世纪,中国天然药物研究要在国际上占有重要位置,突破口便是中药复方现代化,其关键之一便是化学(有效)成分研究。从中草药中发现有效成分或先导物必须采用化学成分与生物活性研究融为一体的机制,采用高通量筛选,目标就是寻找有效成分或先导物进而创制新药。长短结合,正确处理知识创新和新药开发的关系。知识创新须体现在创制新药的应用基础研究中,是产生巨大效益的理论基础;短程开发是知识累积水平的体现,是科研经费的必要补充和保证。改革传统天然产物化学研究模式,实施以当代最先进大型谱仪为先导的天然产物研究战略。
Wei Wang,Bhavitavya Nijampatnam,Sadanandan E. Velu,Ruiwen Zhang
《化学科学与工程前沿(英文)》 2016年 第10卷 第1期 页码 1-15 doi: 10.1007/s11705-016-1562-6
关键词: synthesis marine drugs tricyclic pyrroloquinone alkaloid cancer therapy MDM2 p53
标题 作者 时间 类型 操作
Repurposing clinical drugs is a promising strategy to discover drugs against Zika virus infection
Weibao Song, Hongjuan Zhang, Yu Zhang, Rui Li, Yanxing Han, Yuan Lin, Jiandong Jiang
期刊论文
Occurrence, distribution and risk assessment of abused drugs and their metabolites in a typical urban
Peng Hu, Changsheng Guo, Yan Zhang, Jiapei Lv, Yuan Zhang, Jian Xu
期刊论文
Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)
期刊论文
nanocarriers for efficient cellular uptake and endosomal release of small molecule and nucleic acid drugs
Vaibhav Mundra, Ram I. Mahato
期刊论文
Product identification and toxicity change during oxidation of methotrexate by ferrate and permanganate in water
期刊论文
Factors related to compliance with oral analgesic treatment of inpatients with chronic pain
null
期刊论文
Theoretical insights into influence of additives on sulfamethoxazole crystal growth kinetics and mechanisms
期刊论文